Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Arm Single Center Clinical Trial of Pamiparib (BGB-290) for EGFR TKIs Resistant Non-small Cell Lung Cance

NCT05573373 is registered in ClinicalTrials.gov with Affiliated Hospital of Jiangnan University as lead sponsor.

NCT NCT05573373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05573373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Arm Single Center Clinical Trial of Pamiparib (BGB-290) for EGFR TKIs Resistant Non-small Cell Lung Cance
Lead sponsor
Affiliated Hospital of Jiangnan University
Phase
Phase 1
Overall status
Unknown status
Start date
December 20, 2022
Completion date
December 30, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, egf-r positive non-small cell lung cancer